Cannell & Spears’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$16.7M Sell
39,143
-298
-0.8% -$122K 0.3% 77
2026
Q2
$15.4M Sell
39,441
-851
-2% -$360K 0.27% 86
2026
Q1
$19.1M Sell
40,292
-2,446
-6% -$1.23M 0.37% 73
2025
Q4
$20M Sell
42,738
-1,340
-3% -$622K 0.37% 73
2025
Q3
$18.8M Sell
44,078
-408
-0.9% -$158K 0.35% 81
2025
Q2
$17M Sell
44,486
-631
-1% -$227K 0.34% 81
2025
Q1
$15.6M Sell
45,117
-1,296
-3% -$417K 0.34% 82
2024
Q4
$13.9M Sell
46,413
-980
-2% -$342K 0.29% 83
2024
Q3
$19.3M Sell
47,393
-288
-0.6% -$105K 0.38% 76
2024
Q2
$15.3M Sell
47,681
-1,681
-3% -$546K 0.32% 76
2024
Q1
$16.5M Buy
+49,362
New +$15.1M 0.34% 79

Other funds holding HCA

Cannell & Spears's HCA Position: Q3 2026 in Review

Cannell & Spears reduced its HCA Healthcare (HCA) stake by 0.76% in Q3 2026, selling an estimated $122K and leaving 39,143 shares worth $16.7M. The position accounts for 0.3% of the portfolio, ranked #77.

Cannell & Spears first reported a position in HCA in Q1 2024 and has held it in 11 quarters since. The position peaked at $20M in Q4 2025. 1,350 funds tracked by Wall St. Rank hold HCA as of Q3 2026.

  • Cannell & Spears held 39,143 shares of HCA Healthcare worth $16.7M as of Q3 2026.
  • Cannell & Spears sold 298 HCA Healthcare shares in Q3 2026, an estimated $122K.
  • HCA Healthcare made up 0.3% of Cannell & Spears's portfolio in Q3 2026, its #77 holding.
  • Cannell & Spears first reported a position in HCA Healthcare in Q1 2024 and has held it in 11 quarters since.
  • Cannell & Spears's HCA Healthcare position peaked at $20M in Q4 2025.
  • 1,350 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2026.

Based on Cannell & Spears's 13F filing for Q3 2026, filed 12 Nov 2026.